Abstract
Cardiovascular diseases are presently the leading cause of death worldwide. Prescribed drugs in terms of therapeutic modalities of clinical management have treated patients, but still a limitation exists. This administered drug displays unwanted health adversity due to the side effects. In this regard, the current focus has been drawn towards nanomedicine-based drug formulation, which illustrates better therapeutic ability, sustained release, bioavailability and less toxicity. To address this, various nanocarriers are developed and are being involved in and studied for clinical application. In this chapter, the potential application of different nanocarrier-based therapeutic delivery has been discussed.
Keywords: Coronary artery disease, Dendrimers, Liposomes, Nanomedicine, Polymeric.
Related Journals
Current Dentistry
Current Traditional Medicine
Adolescent Psychiatry
New Emirates Medical Journal
Current Drug Targets - Cardiovascular & Hematological Disorders
Current Medicinal Chemistry - Cardiovascular & Hematological Agents
Current Cardiology Reviews
Current Hypertension Reviews
Cardiovascular & Hematological Agents in Medicinal Chemistry
Cardiovascular & Hematological Disorders-Drug Targets
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents